Nelson Vergel
Founder, ExcelMale.com
This new safety information about all PED5 inhibitor erectile dysfunction drugs was added by the FDA to all labels of these drugs (Viagra, Cialis, Levitra, Stendra)
[h=4]5 WARNINGS AND PRECAUTIONS[/b][h=5]5.4 Effects on the Eye[/b]Physicians should advise patients to stop use of all phosphodiesterase type 5 (PDE5) inhibitors, including LEVITRA, and seek medical attention in the event of sudden loss of vision in one or both eyes. Such an event may be a sign of nonarteritic anterior ischemic optic neuropathy (NAION), a rare condition and a cause of decreased vision, including permanent loss of vision, that has been reported rarely postmarketing in temporal association with the use of all PDE5 inhibitors.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm203554.htm
[h=4]5 WARNINGS AND PRECAUTIONS[/b][h=5]5.4 Effects on the Eye[/b]Physicians should advise patients to stop use of all phosphodiesterase type 5 (PDE5) inhibitors, including LEVITRA, and seek medical attention in the event of sudden loss of vision in one or both eyes. Such an event may be a sign of nonarteritic anterior ischemic optic neuropathy (NAION), a rare condition and a cause of decreased vision, including permanent loss of vision, that has been reported rarely postmarketing in temporal association with the use of all PDE5 inhibitors.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm203554.htm
